Connie I. Diakos
Sydney, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications
Efficacy of peptide receptor radionuclide therapy in patients with oligodiscordant gastroenteropancreatic neuroendocrine tumours.
Journal: European journal of nuclear medicine and molecular imaging
Published: April 15, 2026
Dual-Threshold Contouring for [68Ga]Ga-DOTATATE PET/CT and Correlation with Overall Survival in Patients with Neuroendocrine Neoplasms.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: March 13, 2026
ASO Visual Abstract: Circulating Extracellular Vesicle Biomarkers as Diagnostic and Prognostic Biomarkers of Liver Metastasis in Colorectal Cancer: A Systematic Review.
Journal: Annals of surgical oncology
Published: March 02, 2026
Overall survival with relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): a phase 3 randomised controlled trial.
Journal: Lancet (London, England)
Published: February 10, 2026
Two Decades of Multimodal Management of Colorectal Liver Metastases With Long-Term Outcomes.
Journal: ANZ journal of surgery
Published: November 30, 2025
Therapy-related myeloid neoplasms following peptide receptor radionuclide therapy for neuroendocrine neoplasms: case series reporting characteristics and outcomes from single-centre experience.
Journal: Endocrine oncology (Bristol, England)
Published: November 26, 2025
Vaccine-induced immunity is maintained in glioma patients relative to other solid tumours.
Journal: Journal of neuro-oncology
Published: September 02, 2025
Circulating Extracellular Vesicle Biomarkers as Diagnostic and Prognostic Biomarkers of Liver Metastasis in Colorectal Cancer: A Systematic Review.
Journal: Annals of surgical oncology
Published: August 18, 2025
[18F]FMISO PET in metastatic neuroendocrine tumours: a pilot study.
Journal: Asia Oceania journal of nuclear medicine & biology
Published: June 30, 2025
Outcomes for Patients With Micro-Invasive or Small HER2+ Breast Cancer in Northern Sydney Local Health District.
Journal: Asia-Pacific journal of clinical oncology
Published: May 18, 2025
Relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): an open-label, randomised, controlled, phase 3 trial.
Journal: Lancet (London, England)
Published: April 16, 2025
Last Updated: 09/26/2026